16. Scott JK, Smith GP (1990) Searching for peptide ligands with an epitope library. Science 249: 386–390. 17. Felici F, Luzzago A, Folgori A, Cortese R (1993) Mimicking of discontinuous epitopes by phage-displayed peptides, II. Selection of clones recognized by a protective monoclonal antibody against the Bordetella pertussis toxin from phage peptide libraries. Gene 128: 21–27. 18. Luzzago A, Felici F, Tramontano A, Pessi A, Cortese R (1993) Mimicking of discontinuous epitopes by phage-displayed peptides, I. Epitope mapping of human H ferritin using a phage library of constrained peptides. Gene 128: 51–57. 19. Chen Y, Emtage P, Zhu Q, Foley R, Muller W, et al. (2001) Induction of ErbB- 2/neu-specific protective and therapeutic antitumor immunity using genetically modified dendritic cells: enhanced efficacy by cotransduction of gene encoding IL-12. Gene Ther 8: 316–323. 20. Kianizad K, Marshall LA, Grinshtein N, Bernard D, Margl R, et al. (2007) Elevated frequencies of self-reactive CD8+ T cells following immunization with a xenoantigen are due to the presence of a heteroclitic CD4+ T-cell helper epitope. Cancer Res 67: 6459–6467. 21. Lane C, Leitch J, Tan X, Hadjati J, Bramson JL, et al. (2004) Vaccination- induced autoimmune vitiligo is a consequence of secondary trauma to the skin. Cancer Res 64: 1509–1514. 22. Pupa SM, Iezzi M, Di Carlo E, Invernizzi A, Cavallo F, et al. (2005) Inhibition of mammary carcinoma development in HER-2/neu transgenic mice through induction of autoimmunity by xenogeneic DNA vaccination. Cancer Res 65: 1071–1078. 23. Quaglino E, Iezzi M, Mastini C, Amici A, Pericle F, et al. (2004) Electroporated DNA vaccine clears away multifocal mammary carcinomas in her-2/neu transgenic mice. Cancer Res 64: 2858–2864. 24. Rovero S, Amici A, Carlo ED, Bei R, Nanni P, et al. (2000) DNA vaccination against rat her-2/Neu p185 more effectively inhibits carcinogenesis than transplantable carcinomas in transgenic BALB/c mice. J Immunol 165: 5133–5142. 25. Zacher AN 3rd, Stock CA, Golden JW 2nd, Smith GP (1980) A new filamentous phage cloning vector: fd-tet. Gene 9: 127–140. 26. Batori V, Friis EP, Nielsen H, Roggen EL (2006) An in silico method using an epitope motif database for predicting the location of antigenic determinants on proteins in a structural context. J Mol Recognit 19: 21–29. 27. Franklin MC, Carey KD, Vajdos FF, Leahy DJ, de Vos AM, et al. (2004) Insights into ErbB signaling from the structure of the ErbB2-pertuzumab complex. Cancer Cell 5: 317–328. Epitope Mapping with Mimotopes 28. Hopp TP, Woods KR (1981) Prediction of protein antigenic determinants from amino acid sequences. Proc Natl Acad Sci U S A 78: 3824–3828. 29. Westhof E, Altschuh D, Moras D, Bloomer AC, Mondragon A, et al. (1984) Correlation between segmental mobility and the location of antigenic determinants in proteins. Nature 311: 123–126. 30. Novotny J, Handschumacher M, Haber E (1986) Location of antigenic epitopes on antibody molecules. J Mol Biol 189: 715–721. 31. Thornton JM, Edwards MS, Taylor WR, Barlow DJ (1986) Location of ‘continuous’ antigenic determinants in the protruding regions of proteins. EMBO J 5: 409–413. 32. Gershoni JM, Denisova G, Raviv D, Smorodinsky NI, Buyaner D (1993) HIV binding to its receptor creates specific epitopes for the CD4/gp120 complex. FASEB J 7: 1185–1187. 33. Ikeda Y, Toda G, Hashimoto N, Maruyama T, Oka H (1987) Antibody that recognizes conformations of calmodulin in the serum from patient with chronic active hepatitis. Biochem Biophys Res Commun 144: 191–197. 34. Thali M, Moore JP, Furman C, Charles M, Ho DD, et al. (1993) Characterization of conserved human immunodeficiency virus type 1 gp120 neutralization epitopes exposed upon gp120-CD4 binding. J Virol 67: 3978–3988. 35. Bramson JL, Dayball K, Hall JR, Millar JB, Miller M, et al. (2003) Super- activated interferon-regulatory factors can enhance plasmid immunization. Vaccine 21: 1363–1370. 36. Dayball K, Millar J, Miller M, Wan YH, Bramson J (2003) Electroporation enables plasmid vaccines to elicit CD8+ T cell responses in the absence of CD4+ T cells. J Immunol 171: 3379–3384. 37. Boggio K, Nicoletti G, Di Carlo E, Cavallo F, Landuzzi L, et al. (1998) Interleukin 12-mediated prevention of spontaneous mammary adenocarcinomas in two lines of Her-2/neu transgenic mice. J Exp Med 188: 589–596. 38. Bonnycastle LL, Mehroke JS, Rashed M, Gong X, Scott JK (1996) Probing the basis of antibody reactivity with a panel of constrained peptide libraries displayed by filamentous phage. J Mol Biol 258: 747–762. 39. Smith GP Phage-Display Vectors and Libraries Based on Filamentous Phage Strain fd-tet http://wwwbioscimissouriedu/smithgp/PhageDisplayWebsite/ PhageDisplayWebsiteIndex.html. 40. Enshell-Seijffers D, Gershoni JM (2002) Phage display selection and analysis of Ab-binding epitopes. Curr Protoc Immunol;chapter 9. 41. Haste Andersen P, Nielsen M, Lund O (2006) Prediction of residues in discontinuous B-cell epitopes using protein 3D structures. Protein Sci 15: 2558–2567. PLoS ONE | www.plosone.org 11 April 2009 | Volume 4 | Issue 4 | e5309